81 related articles for article (PubMed ID: 494629)
1. [Level of fibrinogen/fibrin degradation products (F/FDP) in certain internal diseases].
Alakhverdian R; Denchev K
Vutr Boles; 1979; 18(4):28-32. PubMed ID: 494629
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic activity in coronary heart disease.
Yao SK; Chen ZJ; Tao SQ
Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
[TBL] [Abstract][Full Text] [Related]
3. [Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
Grinshteĭn IA; Ignashenkova GV; Kitaev MI
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):18-21. PubMed ID: 3300697
[TBL] [Abstract][Full Text] [Related]
4. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
[TBL] [Abstract][Full Text] [Related]
5. [Clinical value of studying fibrinogen degradation products in patients with ischemic heart disease].
Ikonnikova EI; Katkova NB; Filippova SB
Klin Med (Mosk); 1989 May; 67(5):35-6. PubMed ID: 2770207
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
Wilson JE; Thornton RD
Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
[TBL] [Abstract][Full Text] [Related]
7. [Fibrin/fibrinogen degradation products in the diagnosis of pulmonary thromboembolism].
Ena IaM; Drannik GN; Konopleva LF
Ter Arkh; 1985; 57(4):143-6. PubMed ID: 3892752
[No Abstract] [Full Text] [Related]
8. [Studies on plasma F. XIII subunit a level and the detection of soluble fibrin monomer in collagen diseases].
Okubo S; Suzuki H; Ishida T; Yasunaga K
Rinsho Ketsueki; 1986 Aug; 27(8):1339-44. PubMed ID: 3795511
[No Abstract] [Full Text] [Related]
9. [The levels of FDP, FDP-E and D-dimer in patients with rheumatoid arthritis].
Nakashima M; Aoyagi T; Aratake K; Kawabe Y; Eguchi K
Ryumachi; 1998 Dec; 38(6):793-800. PubMed ID: 10047717
[TBL] [Abstract][Full Text] [Related]
10. [Fibrinogen and fibrin degradation products in the blood of acute myocardial infarct patients at the hospital rehabilitation stage].
Solov'ev AV; Ermolin GA; Ignashenkova GV; Dikov MM
Ter Arkh; 1987; 59(10):21-3. PubMed ID: 3324376
[TBL] [Abstract][Full Text] [Related]
11. [Serum contraction of FDP (fibrin degradation products) in acute pulmonary embolism].
Patiño R; Corral EF; Cerda E; de la Serna JL; Durán Sacristán M
Rev Esp Cardiol; 1976; 29(1):3-8. PubMed ID: 1257540
[No Abstract] [Full Text] [Related]
12. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
Malaia LT; Volkov VI; Topchiĭ II; Dykun IaV; Shuliak LN
Ter Arkh; 1990; 62(11):87-90. PubMed ID: 2095000
[TBL] [Abstract][Full Text] [Related]
13. The value of serum fibrinogen degradation products in the differential diagnosis between acute myocardial infarction and pulmonary embolism.
Buch J
Acta Cardiol; 1979; 34(3):179-87. PubMed ID: 315686
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
Dudaev VA; Diukov IV; Borodkin VV
Ter Arkh; 1986; 58(12):62-7. PubMed ID: 3824217
[TBL] [Abstract][Full Text] [Related]
15. [Fibrin fibrinogen degradation products in the blood in systemic lupus erythematosus and other major collagen diseases].
Wysocka K; Kiczak J
Reumatologia; 1982; 20(1-2):15-21. PubMed ID: 7163659
[No Abstract] [Full Text] [Related]
16. Relations between fibrinogen degradation products and heparinocytes.
Frick G; Frick U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):271-6. PubMed ID: 61922
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
Chen JP; Williams TK; Legendre AM
Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen/fibrin degradation products in serum of patients with idiopathic thrombocytopenic purpura: elevated levels during severe thrombocytopenic phase of the disease.
Nagasawa T; Kono I; Sakurai T; Kashiwagi H
Thromb Haemost; 1976 Jun; 35(3):628-34. PubMed ID: 989969
[TBL] [Abstract][Full Text] [Related]
19. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of serum fibrinogen degradation products using gel chromatography and radioimmunoassay.
Ratky SM; Sykes A; Cooke ED; Gordon YB
Thromb Haemost; 1977 Jun; 37(3):471-6. PubMed ID: 578027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
